Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)

China flag China · Delayed Price · Currency is CNY
25.89
+0.69 (2.74%)
At close: Apr 29, 2026
101.48%
Market Cap 10.27B
Revenue (ttm) 1.94B
Net Income (ttm) 119.05M
Shares Out 396.81M
EPS (ttm) 0.30
PE Ratio 86.33
Forward PE n/a
Dividend 0.03 (0.12%)
Ex-Dividend Date Jun 25, 2025
Volume 37,224,810
Average Volume 22,058,327
Open 25.27
Previous Close 25.20
Day's Range 23.59 - 26.04
52-Week Range 12.64 - 28.79
Beta 0.47
RSI 61.96
Earnings Date Apr 29, 2026

About SHE:301246

Hubei Hongyuan Pharmaceutical Technology Co., Ltd., together with its subsidiaries, produces and sells pharmaceutical products in China and internationally. The company offers active pharmaceutical ingredients, such as metronidazole, benzoyl metronidazole, dimetrizole, and acyclovir; pharmaceutical intermediates, including imidazole, glyoxylic acid, 2-methyl imidazole, 2-methyl-5-nitroimidazole, sulfate, guanine, diacetyl guanine, and diacetylacyclovir; organic chemical raw materials comprising glyoxal, and oxalic acid; and new energy materials... [Read more]

Sector Healthcare
Founded 2002
Employees 2,169
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301246
Full Company Profile

Financial Performance

In 2025, SHE:301246's revenue was 1.94 billion, an increase of 9.53% compared to the previous year's 1.77 billion. Earnings were 119.05 million, an increase of 131.33%.

Financial Statements

News

There is no news available yet.